RxDoctor Payments Data

Stephanie Lovato, PA

Medical · Bluffton, SCNPI 1912165390

Payments from drug & device makers

$2,520in general payments, 2019–2025

Across 144 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$468
  • Novo Nordisk$333
  • Lilly USA, LLC$300
  • AbbVie$214
  • Biohaven Pharmaceutical Holding Company Ltd.$168
  • Boehringer Ingelheim$134
  • plus $902 from 21 others

What the payments were for

  • Food & beverage$2,520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,520 in reported general payments places this provider in the 70th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$135,493
Medicare patients
466
Services billed
1,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$99,730
JardianceEmpagliflozin87$84,895
MounjaroTirzepatide39$40,188
JanuviaSitagliptin Phosphate40$38,316
EliquisApixaban35$36,505
Tresiba Flextouch U-200Insulin Degludec24$11,234
SynthroidLevothyroxine Sodium121$9,031
GemtesaVibegron14$6,417
SymbicortBudesonide/Formoterol Fumarate14$5,053
Dexlansoprazole DrDexlansoprazole13$4,269
Levothyroxine Sodium242$4,106
Valsartan105$3,339
Atorvastatin Calcium279$3,030
Omeprazole160$2,765
Rosuvastatin Calcium195$2,148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$333$99,73069 claims
Boehringer IngelheimJardiance$134$84,89587 claims
Lilly USA, LLCMounjaro$300$40,18839 claims
PfizerEliquis$468$36,50535 claims
AbbVieSynthroid$214$9,031121 claims
AstraZenecaSymbicort$60$5,05314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 384 medical providers in South Carolina.

Other medical in Bluffton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →